TNFRSF4 and malignant colon neoplasm: In colon cancer cell (MC38)-grafted hPD-L1/hOX40-expressing mice, and colon cancer cell (CT26) human PD-1/PD-L1/OX40-expressing mice, the administration of EMB-09 strongly inhibited tumor growth, as compared to atezolizumab [141].